Jing Li

Researcher
DISC Type : Cs

Director, Bioanalytical Sciences at Alnylam Pharmaceuticals

Cambridge, Massachusetts, United States

Overview

Jing Li is the Director of Bioanalytical Sciences at Alnylam Pharmaceuticals, specializing in RNAi therapeutics. With a Ph. D. from the University of Chicago, she leads efforts in developing and qualifying LC-MS/MS bioanalytical methods to support pharmacokinetic and toxicokinetic studies for novel drug programs.


Her work focuses on the metabolic profiling of siRNA compounds to understand their stability and advance them from discovery to the clinic.

Personality Overview

Process Focused

Perfectionist

Self-Disciplined

They do not like taking risks at all and go for proven options in the end.  Being observant comes to them naturally. They tend to be clear about their needs and limitations and are unlikely to promise too much.

Topics They Care About

RNAi Therapeutics
Her entire career at Alnylam, the leading RNAi company, has been dedicated to advancing this class of therapeutics through bioanalytical science.
Mass Spectrometry
She specializes in developing and qualifying LC-MS and LC-MS/MS methods for quantitating siRNA compounds in biological matrices to support drug development.
Drug Metabolism
She performs metabolic profiling of siRNA compounds to understand their stability and has co-authored multiple papers on the pharmacokinetics and ADME of RNAi drugs.

Media Appearances

Jing has no verified media appearances

Work History

10-2024
Director, Bioanalytical Sciences at Alnylam Pharmaceuticals
7-2022 - 9-2024
Associate Director, Bioanalytical Sciences at Alnylam Pharmaceuticals
7-2019 - 6-2022
Principal Scientist, Bioanalytical Sciences at Alnylam Pharmaceuticals
7-2017 - 6-2019
Senior Scientist, Bioanalytical Sciences at Alnylam Pharmaceuticals
11-2015 - 6-2017
Scientist, Bioanalytical Sciences at Alnylam Pharmaceuticals

Education

2003 - 2010
Ph.D. from University of Chicago
1999 - 2003
B.S. from Tsinghua University

More Information

Social Presence :

Prographics :

Exp : 14 Location : Cambridge, Massachusetts, United States Job Level : Mid-senior Designation : Director, Bioanalytical Sciences at Alnylam Pharmaceuticals
URL has been copied!

Insights For Selling To Jing

During A Call Or A Meeting

DO's

  • Share a one-off customer success story but keeps the focus on highlighting objective, numerical results
  • Actively address their concerns around change, risk, and acceptance by users
  • When following up with them, expect slowness; use questions to engage them, preferably over email.

DONT's

  • Avoid emotional and informal language, stay objective and to the point instead
  • Don’t overhype the product/pitch, keep it measured
  • Don't ask them to move fast, let them take their time and digest all the information

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Jing is

  • For them, low risk and acceptance by others are very important, followed by proof of ROI.
  • Will you ever get a clear answer from Jing

  • Often, they don't say no, or keep going about it in circles.

Insights For Deal Planning

    How fast (or slow) will Jing move?

  • They do not like to take decisions in a hurry, so they could be slow in making their mind up.
  • Can Jing take some risk or not?

  • They are low on risk-appetite and prefer to make informed decisions.

You And Jing

Personality Compatibility


Other Alnylam Pharmaceuticals Employees

Explore more public profiles from related professionals at the same organization.

More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.